Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
8.43
-0.33 (-3.77%)
At close: May 21, 2025, 4:00 PM
8.45
+0.02 (0.19%)
After-hours: May 21, 2025, 7:35 PM EDT
Organon & Co. Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Organon & Co. stock ranges from a low of $10 to a high of $24. The average analyst price target of $18 forecasts a 113.52% increase in the stock price over the next year.
Price Target: $18.00 (+113.52%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +113.52% | May 15, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +18.62% | May 5, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +77.94% | Apr 9, 2025 |
Barclays | Barclays | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +184.70% | Feb 14, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +89.80% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
6.27B
from 6.40B
Decreased by -2.09%
Revenue Next Year
6.33B
from 6.27B
Increased by 1.04%
EPS This Year
3.81
from 3.33
Increased by 14.35%
EPS Next Year
4.03
from 3.81
Increased by 5.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 6.6B | 6.7B | 6.8B | ||
Avg | 6.3B | 6.3B | 6.4B | ||
Low | 6.0B | 6.0B | 6.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.1% | 7.0% | 7.5% | ||
Avg | -2.1% | 1.0% | 1.2% | ||
Low | -6.0% | -5.0% | -4.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.05 | 4.55 | 4.52 | ||
Avg | 3.81 | 4.03 | 4.13 | ||
Low | 3.59 | 3.63 | 3.71 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.7% | 19.4% | 11.9% | ||
Avg | 14.3% | 5.9% | 2.4% | ||
Low | 7.7% | -4.8% | -7.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.